Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Living in a world of disappearing nature: physical risk and the implications for financial stability
A thriving nature provides many benefits that sustain human well-being and the global economy. Unfortunately, intensive land use, climate change,…
Sustainability Reporting & Data Collection Strategies Outlook 2024
Sustainability reporting poses one of the most significant challenges for sustainability professionals today. The regulatory need for reporting – and…
Investing with Nature: Exploring Investment Opportunities Across Ecosystems. First-1. Introduction to Nature-based Solutions
Financial institutions have a unique role to play in scaling up nature-based solutions (NBS), specifically in closing the large private…